 Multimodal therapy advanced breast carcinoma patients breast cancer disease subgroup untreated advanced disease demonstrable distant metastases time diagnosis stage IIIB MO first years patients sequential radiotherapy chemotherapy Group Group management courses induction multi-drug chemotherapy mastectomy additional chemotherapy mean follow-up recent group Group months Follow-up complete local disease control rate groups survival different Group patients median survival months years Group median survival months patients alive months survivors overall mortality patients inflammatory breast cancer groups group noninflammatory disease survival patients Group Group inflammatory noninflammatory cancers Estrogen receptor nodal menopausal status survival data neoadjuvant chemotherapy survival patients stage IIIB breast carcinoma establishment progression distant metastases Mastectomy important component treatment disease